These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 1318371)

  • 1. Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies.
    Facklam M; Schoch P; Bonetti EP; Jenck F; Martin JR; Moreau JL; Haefely WE
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1113-21. PubMed ID: 1318371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between benzodiazepine receptor occupancy and potentiation of gamma-aminobutyric acid-stimulated chloride flux in vitro of four ligands of differing intrinsic efficacies.
    Facklam M; Schoch P; Haefely WE
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1106-12. PubMed ID: 1318370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors.
    Giusti P; Ducić I; Puia G; Arban R; Walser A; Guidotti A; Costa E
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1018-28. PubMed ID: 8394902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.
    Jenck F; Moreau JL; Bonetti EP; Martin JR; Haefely WE
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1121-7. PubMed ID: 1356150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
    Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CGS 9896: agonist-antagonist benzodiazepine receptor activity revealed by anxiolytic, anticonvulsant and muscle relaxation assessment in rodents.
    Bernard PS; Bennett DA; Pastor G; Yokoyama N; Liebman JM
    J Pharmacol Exp Ther; 1985 Oct; 235(1):98-105. PubMed ID: 2995650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vigabatrin modulates benzodiazepine receptor activity in vivo: a positron emission tomography study in baboon.
    Schmid L; Bottlaender M; Brouillet E; Fuseau C; Mazière M
    J Pharmacol Exp Ther; 1996 Mar; 276(3):977-83. PubMed ID: 8786578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo bidirectional modulatory effect of benzodiazepine receptor ligands on GABAergic transmission evaluated by positron emission tomography in non-human primates.
    Brouillet E; Chavoix C; Bottlaender M; Khalili-Varasteh M; Hantraye P; Fournier D; Dodd RH; Mazière M
    Brain Res; 1991 Aug; 557(1-2):167-76. PubMed ID: 1660750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
    Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
    Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil.
    Rundfeldt C; Wlaź P; Hönack D; Löscher W
    J Pharmacol Exp Ther; 1995 Nov; 275(2):693-702. PubMed ID: 7473156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
    Dubinsky B; Vaidya AH; Rosenthal DI; Hochman C; Crooke JJ; DeLuca S; DeVine A; Cheo-Isaacs CT; Carter AR; Jordan AD; Reitz AB; Shank RP
    J Pharmacol Exp Ther; 2002 Nov; 303(2):777-90. PubMed ID: 12388665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of benzodiazepine receptor ligands with partial agonistic, antagonistic or partial inverse agonistic properties in precipitating withdrawal in squirrel monkeys.
    Martin JR; Jenck F; Moreau JL
    J Pharmacol Exp Ther; 1995 Oct; 275(1):405-11. PubMed ID: 7562578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mouse beam walking assay offers improved sensitivity over the mouse rotarod in determining motor coordination deficits induced by benzodiazepines.
    Stanley JL; Lincoln RJ; Brown TA; McDonald LM; Dawson GR; Reynolds DS
    J Psychopharmacol; 2005 May; 19(3):221-7. PubMed ID: 15888506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial agonists of the benzodiazepine receptor: from animal data to results in patients.
    Haefely W
    Adv Biochem Psychopharmacol; 1988; 45():275-92. PubMed ID: 2459921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
    Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.
    McKernan RM; Rosahl TW; Reynolds DS; Sur C; Wafford KA; Atack JR; Farrar S; Myers J; Cook G; Ferris P; Garrett L; Bristow L; Marshall G; Macaulay A; Brown N; Howell O; Moore KW; Carling RW; Street LJ; Castro JL; Ragan CI; Dawson GR; Whiting PJ
    Nat Neurosci; 2000 Jun; 3(6):587-92. PubMed ID: 10816315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial agonists of benzodiazepine receptors for the treatment of epilepsy, sleep, and anxiety disorders.
    Haefely W; Facklam M; Schoch P; Martin JR; Bonetti EP; Moreau JL; Jenck F; Richards JG
    Adv Biochem Psychopharmacol; 1992; 47():379-94. PubMed ID: 1324584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of behavioral effects of bretazenil by flumazenil and ZK 93,426 in pigeons.
    Witkin JM; Acri JB; Gleeson S; Barrett JE
    Pharmacol Biochem Behav; 1997 Jan; 56(1):1-7. PubMed ID: 8981602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors.
    Cox ED; Diaz-Arauzo H; Huang Q; Reddy MS; Ma C; Harris B; McKernan R; Skolnick P; Cook JM
    J Med Chem; 1998 Jul; 41(14):2537-52. PubMed ID: 9651158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. I. Psychopharmacological profile in rodents.
    Keane PE; Simiand J; Morre M; Biziere K
    J Pharmacol Exp Ther; 1988 May; 245(2):692-8. PubMed ID: 2896794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.